Business Valuation

Initial Public Offering (IPO)

Financial Reporting

Corporate Transaction 

A growing attention to the Biotech sector has been shown in the accelerating investments by Venture Capital funds and IPOs, as well as the expectation of innovative therapies amidst Covid-19. This article, therefore, provides a guide on Biotech investment analysis with highlighting the “3H” characteristics of Biotech industry—High inputs in R&amp;D, High Rewards, and High Risks, and demonstrating related valuation approaches for quantitative analysis.
 
Click <a href="../../../../../uploads/Investing_in_Biotech_-_A_Guide_to_Risk-Return_Analysis_with_Valuation_Techniquesv2_d1bdf4f384.pdf" target="_blank" rel="noopener">here</a> to read the full article.
 
<a href="../../../../../uploads/Investing_in_Biotech_-_A_Guide_to_Risk-Return_Analysis_with_Valuation_Techniquesv2_d1bdf4f384.pdf" target="_blank" rel="noopener"><img src="../../../../../uploads/cover_51fccbbb2f.jpeg" width="600" /></a>

127134377_m

CFA, FCPA, FCPA (Aust.), MRICS, RICS Registered Valuer
Vincent is the Founder and Managing Partner of AVISTA Group, who leads the firm’s Valuation Advisory, Risk Management Advisory, ESG Advisory and Corporate Advisory services in Hong Kong and the PRC.
Vincent has over 20 years of experiences in valuation advisory, M&amp;A advisory, business consulting and corporate investment, advising clients in a range of industries, including TMT, financial services, pharmaceutical, energy and etc. Hence, leading the firm to make breakthroughs in these areas.
Before founding AVISTA, Vincent served as an Associate Director of PwC and was in charge of the valuation division in Beijing. He has advised numerous large M&amp;A deals in both China and overseas for multinational corporations and Chinese state-owned enterprises. He also has extensive experiences in providing valuation services for US and HK IPO listing.
Vincent is the Vice Chairman of Business Valuation Committee and the Executive Council Member of The Hong Kong Independent Non-Executive Director Association (HKiNEDA), Reviewer of HKICPA Best Corporate Governance and ESG Awards, Head Juror of Institute of ESG and Benchmark (iESGB) Achievement Awards, and the member of Financial Reporting Valuation Advisory Panel of HKICPA.

VINCENT PANG

Managing Partner

ACA, CFA, FCPA, LL.M, MRICS, RICS Registered Valuer
Ivan is mainly responsible for business valuation, intangible asset valuation and financial instruments valuation for financial reporting purpose and consulting &amp; advisory purpose.
Ivan has over 10 years’ experience in valuation sector. Prior to joining AVISTA, Ivan has worked with KPMG in Risk Advisory Service and Assurance Departments. Ivan has led several local and overseas valuation and advisory projects across different industries for transaction, IPO and financial reporting purposes.

IVAN LUI

Partner

Hailey is responsible for business valuation, intangible asset valuation and financial instrument valuation service for financial reporting and consulting purposes.
Hailey graduated from Shanghai Jiao Tong University Antai College and has over 10 years’ experience in valuation service and M&amp;A financial advisory service in China. Before joining AVISTA, Hailey was a manager in PricewaterhouseCoopers with working experience in both Valuation Service and Corporate Finance Department.
During the past years, Hailey has participated in several large M&amp;A deals to provide modeling, pricing valuation or valuation advisory service. Besides, she was involved in numerous projects for US and HK listed or pre-IPO listing companies to review their valuation prepared for financial reporting purpose. In addition, she also acted as a financial advisor for several private equity financing and outbound acquisition projects.

HAILEY JIN

Investing in Biotech - A Guide to Risk-Return Analysis with Valuation Techniques

The Stock Exchange of Hong Kong Limited (the “HKEX”) has published the Guide for New Listing Applicants (the “Guide”), effective from 1 January 2024, introducing the new chapter on prospectus disclosure requirements and guidance in relation to Corporate Governance and Environmental, Social and Governance (“ESG”) (Chapter4.3 of the Guide). Listing applicants should pay attention to the impact of the Guide on the contents of the prospectus, in order to timely assess and optimize the proposed listing timetable.
 
<a href="../../../../../uploads/HKEX_s_Latest_Prospectus_Disclosure_Requirements_on_Corporate_Governance_and_Environmental_Social_and_Governance_under_the_Guide_for_New_Listing_Applicants_V6_5de8f68b61.pdf" target="_blank" rel="noopener">Read the report now</a>
<a href="../../../../../uploads/HKEX_s_Latest_Prospectus_Disclosure_Requirements_on_Corporate_Governance_and_Environmental_Social_and_Governance_under_the_Guide_for_New_Listing_Applicants_V6_5de8f68b61.pdf" target="_blank" rel="noopener"><img src="../../../../../uploads/Screenshot_2024_01_19_at_6_41_52_PM_e6c9255108.png" width="500" /></a>

Screenshot 2024-01-19 at 6.50.37 PM.png

HKEX’s Latest Prospectus Disclosure Requirements on Corporate Governance & Environmental, Social and Governance under the Guide for New Listing Applicants 

As a guidance and enhanced regulations on the compliance audit activities of personal information protection, the Cyberspace Administration of China issued "Administrative Measures for the Personal Information Protection Compliance Audit (Comment Draft)” and the annex of "Reference Points for Compliance Audit of Personal Information Protection" for public comments.
 
Avista extracted some key provisions, with additional interpretation in terms of internal control, to provide personal information processors a better understanding for the regulatory requirements of the personal information protection-related compliance audit.
 
<a href="../../../../../uploads/Highlights_of_the_Compliance_Audit_Requirement_in_the_Administrative_Measures_for_the_Personal_Information_Protection_Compliance_Audit_Comment_Draft_4a2daaddc3.pdf" target="_blank" rel="noopener">Read the report now</a>
<a href="../../../../../uploads/Highlights_of_the_Compliance_Audit_Requirement_in_the_Administrative_Measures_for_the_Personal_Information_Protection_Compliance_Audit_Comment_Draft_4a2daaddc3.pdf" target="_blank" rel="noopener"><img src="../../../../../uploads/Screenshot_2023_11_10_at_2_57_02_PM_69620af56e.png" width="500" /></a>

Screenshot 2023-11-10 at 2.48.31 PM.png

Highlights of the Compliance Audit Requirement in the “Administrative Measures for the Personal Information Protection Compliance Audit (Comment Draft)”

In October 2023, the Stock Exchange of Hong Kong Limited issued a guidance letter on the "Disclosure of the Basis of Consideration and Business Valuations in Notifiable Transactions”. The guidance letter emphasizes the need for listed companies to provide adequate explanation of the basis for determining the consideration of the transaction by disclosing sufficient and objective information in the disclosure documents, and provides guidance on the recommended disclosures.
 
<a href="../../../../../uploads/HK_Ex_Guidance_Letter_on_Disclosure_of_the_Basis_of_Consideration_and_Business_Valuation_in_Notifiable_Transactions_ab6483414a.pdf" target="_blank" rel="noopener">Read the report now</a>
 
<a href="../../../../../uploads/HK_Ex_Guidance_Letter_on_Disclosure_of_the_Basis_of_Consideration_and_Business_Valuation_in_Notifiable_Transactions_ab6483414a.pdf" target="_blank" rel="noopener"><img src="../../../../../uploads/Screenshot_2023_11_01_at_2_19_25_PM_a091602f0e.png" width="500" /></a>